Bruker Corp. (Nasdaq: BRKR), an international life science research and diagnostics services provider, has acquired ELITech Group, a manufacturer of in-vitro diagnostics (IVD), from PAI Partners.
ELITech is focused on developing IVD instruments and reagents, and has market positions within niche IVD segments in molecular diagnostics and microbiology. The company’s products help hospitals and laboratories perform analyses to diagnose diseases, identify disease risk factors and optimize treatment choices.